The Federal Circuit Court of Appeals affirmed on March 20, 2015, the judgment entered in favor of Shaw Keller client Hi-Tech Pharmacal Co. Inc. in an ANDA action brought by Allergan, Inc. in the District of Delaware.  The District of Delaware had found that the Allergan patents were invalid after a one-week trial in January 2013.  Jeff Castellano and Karen Keller were primary counsel for Hi-Tech at trial and for Allergan’s appeal.